The Island-state of Singapore views biosciences and health care servicesas its most promising future economic growth area, hoping that it will complement its existing strengths in electronics, chemicals and transport. The Singapore government is keen to retain its distinction of having one of the most competitive economies in the world. The search for a new industry on which to pin future aspirations has become all the more significant following last year's recession - a consequence of Singapore's over-dependence on electronics, writes John Burton in the Financial Times.
As it bids to become a world leader in biosciences, the Singapore government is encountering problems which may hold back the development of this intended growth area. Firstly, there is a lack of highly-skilled personnel in Singapore to fill the type of roles required to achieve a successful intellectual property base within biosciences. Secondly, Singapore's non-entrepreneurial culture has meant a lack of investment in venture companies.
Lack of highly skilled individuals
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze